• Chief Healthcare ExecutiveChief Healthcare Executive
  • Formulary WatchFormulary Watch
  • Managed Healthcare Executive
  • Medical EconomicsMedical Economics
Managed Healthcare Executive
Managed Healthcare Executive
Resource Centers
View MoreHIVLiver DiseaseSleep DisordersBiosimilarsCovid-19AsthmaMultiple SclerosisPost-Acute CarePrescription Digital TherapeuticsRespiratory ConditionsType II Inflammation
Spotlight
Asembia’s 2022 Specialty Pharmacy SummitAMCP AnnualThe Improving Patient Access PodcastWet Age-Related Macular Degeneration: Understanding Disease Impact and Refining Treatment ApproachesAMCP NexusParadigms in Insulin Use for Type 2 DiabetesPBMI National ConferenceRespiratory ConditionsShort on staff? Efficiency—not hiring—may be the best answerSupporting Better Cancer Care Through Comprehensive Genomic Profiling (CGP)
Business
View MoreBusiness StrategyChronic DiseaseConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology
News
Media
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
Conferences
Publications
MHE Publication
Supplements And Featured Publications
Events
Virtual Events
CME/CE
Resources
PBM Leaders
Sponsored
Sponsored Content
Surveys
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations

© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.

Resource CentersSee All >
  • HIV
  • Liver Disease
  • Sleep Disorders
  • Biosimilars
  • Covid-19
  • Asthma
  • Multiple Sclerosis
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Respiratory Conditions
  • Type II Inflammation
Spotlight
  • Asembia’s 2022 Specialty Pharmacy Summit
  • AMCP Annual
  • The Improving Patient Access Podcast
  • Wet Age-Related Macular Degeneration: Understanding Disease Impact and Refining Treatment Approaches
  • AMCP Nexus
  • Paradigms in Insulin Use for Type 2 Diabetes
  • PBMI National Conference
  • Respiratory Conditions
  • Short on staff? Efficiency—not hiring—may be the best answer
  • Supporting Better Cancer Care Through Comprehensive Genomic Profiling (CGP)
BusinessSee All >
  • Business Strategy
  • Chronic Disease
  • Consumers
  • Drug Costs
  • Drug Pipeline
  • Formulary
  • Health Management
  • Health/Disease Strategy
  • Hospitals & Providers
  • Industry Analysis
  • Pharmacy
  • Politics and Policy
  • Practice Management
  • Reimbursement
  • Technology
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.

Blood Cancer

  1. home
  2. clinical
  3. blood
 

Ibrance Shows Promise in Treatment of Myelofibrosis

September 17, 2021

An Ibrance-Jakafi combination shows promise in a mouse model of myelofibrosis.

Antibodies Go Missing After COVID-19 Vaccination in Some Blood Cancer Patients

September 06, 2021

Lack of antibodies from vaccination mainly affects patients with B cell cancers. Experts say antibodies are just one piece of the puzzle and that other aspects of the immune system fend off serious cases of COVID-19.

3 Important Blood Cancer Drug Approvals You Should Know About

August 13, 2021

The confirmatory trial of one of the approved drugs, Pepaxto, was halted when data suggested it was associated with a higher mortality rate.

2 Acute Lymphoblastic Leukemia Updates

August 10, 2021

NCCN adds Rylaze to guidelines soon after was approved by the FDA and a British company reports positive results for its CAR-T therapy.

3 Updates on Mantle Cell Lymphoma

July 07, 2021

New research and updated treatment guidelines add to knowledge base on this rare blood cancer.

Increasing Access to Blood Cancer Clinical Trials

July 06, 2021

The Leukemia & Lymphoma Society is providing grants to increase trial enrollment of ethnic and racial minorities.

Updates on Pediatric Leukemia Research

June 07, 2021

Researchers are making progress in identifying drugs that target certain mutations.

Positive Results for Vyxeos in Combination With Other Drugs Reported at ASCO Meeting

June 06, 2021

Phase 1b results show manageable toxicities with Venclexta and Rydapt.

3 Updates About Chronic Lymphocytic Leukemia

June 02, 2021

NCCN recommends Brukinsa for CLL/SLL even though it is FDA-approved for mantel cell lymphoma.

Joe Biden Wants to Cure Cancer. Here’s Where to Start

January 20, 2021

Deposing the ‘Emperor of All Maladies’ will take a diverse toolkit, not a single moonshot.